These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 35965439)

  • 1. Intermittent therapy with helicase-primase inhibitor IM-250 efficiently controls recurrent herpes disease and reduces reactivation of latent HSV.
    Bernstein DI; Sawtell NM; Bravo FJ; Dixon DA; Gege C; Kleymann G
    Antiviral Res; 2023 Nov; 219():105733. PubMed ID: 37858763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No Evidence of Pritelivir Resistance Among Herpes Simplex Virus Type 2 Isolates After 4 Weeks of Daily Therapy.
    Edlefsen PT; Birkmann A; Huang ML; Magaret CA; Kee JJ; Diem K; Goldner T; Timmler B; Stoelben S; Ruebsamen-Schaeff H; Zimmermann H; Warren T; Wald A; Corey L
    J Infect Dis; 2016 Jul; 214(2):258-64. PubMed ID: 27056950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Amenamevir, a Helicase-Primase Inhibitor for the Treatment of Acyclovir-Resistant Herpes Simplex Virus 1 Keratitis.
    Boucher R; Boutolleau D; Burrel S; Haigh O; Fernandez J; Vauloup-Fellous C; Barreau E; Rousseau A; Labetoulle M
    Cornea; 2024 Apr; ():. PubMed ID: 38692653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on new antivirals under development for the treatment of double-stranded DNA virus infections.
    Dropulic LK; Cohen JI
    Clin Pharmacol Ther; 2010 Nov; 88(5):610-9. PubMed ID: 20881959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world safety and efficacy of amenamevir in patients with herpes zoster in Japan: A postmarketing observational study (REWARD).
    Imafuku S; Korematsu K; Mori N; Kani T; Matsui K
    J Dermatol; 2023 Oct; 50(10):1287-1300. PubMed ID: 37401122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic strategies for COVID-19: progress and lessons learned.
    Li G; Hilgenfeld R; Whitley R; De Clercq E
    Nat Rev Drug Discov; 2023 Jun; 22(6):449-475. PubMed ID: 37076602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete and Prolonged Inhibition of Herpes Simplex Virus Type 1 Infection In Vitro by CRISPR/Cas9 and CRISPR/CasX Systems.
    Karpov DS; Demidova NA; Kulagin KA; Shuvalova AI; Kovalev MA; Simonov RA; Karpov VL; Snezhkina AV; Kudryavtseva AV; Klimova RR; Kushch AA
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
    Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
    J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicase-primase inhibitors from Medshine Discovery Inc. (WO2018/127207 and WO2020/007355) for the treatment of herpes simplex virus infections - structure proposal for Phaeno Therapeutics drug candidate HN0037.
    Gege C; Kleymann G
    Expert Opin Ther Pat; 2022 Sep; 32(9):933-937. PubMed ID: 35965439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replacement of sulfonamide by sulfoximine within a helicase-primase inhibitor with restricted flexibility.
    Gege C; Kleymann G
    Bioorg Med Chem Lett; 2024 Jul; 106():129761. PubMed ID: 38642810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicase-primase inhibitor amenamevir for herpesvirus infection: Towards practical application for treating herpes zoster.
    Shiraki K
    Drugs Today (Barc); 2017 Nov; 53(11):573-584. PubMed ID: 29451274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amenamevir, a Helicase-Primase Inhibitor, for the Optimal Treatment of Herpes Zoster.
    Shiraki K; Yasumoto S; Toyama N; Fukuda H
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease.
    Crute JJ; Grygon CA; Hargrave KD; Simoneau B; Faucher AM; Bolger G; Kibler P; Liuzzi M; Cordingley MG
    Nat Med; 2002 Apr; 8(4):386-91. PubMed ID: 11927945
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.